Product Information
DIVALPROEX SOD ER 500 MG TAB is a generic product labeled by BluePoint Laboratories, priced at $0.1943 per EA under NDC 68001064703. Its NADAC has been published 43 times since Dec 10, 2025.
FDA first approved this application on Feb 25, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001064703
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIVALPROEX SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA214643FDA Approved
2/25/2022
TE Code
AB
On Market Since
6/6/2025
Pharmacological Classes
Price Statistics
The NADAC for DIVALPROEX SOD ER 500 MG TAB has been published 43 times since Dec 10, 2025, and over the history we have for it it has risen 10.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1943 per EA |
|---|---|
| All-time high | $0.1943 (Sep 30, 2026) |
| All-time low | $0.1679 (Jan 21, 2026) |
| 52-week high | $0.1943 |
| 52-week low | $0.1679 |
| Median price | $0.1759 |
| Average price | $0.1784 |
| Largest weekly change | +7.2% (Apr 22, 2026) |
| Weeks tracked | 43 |
| Tracking since | Dec 10, 2025 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
divalproex sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIVALPROEX SOD ER 500 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DIVALPROEX SOD ER 500 MG TAB, manufactured by BluePoint Laboratories, is $0.1943 per EA (NDC 68001064703), effective Sep 30, 2026.
How has the price of DIVALPROEX SOD ER 500 MG TAB changed over time?
Over the history we have for it, the NADAC for DIVALPROEX SOD ER 500 MG TAB has risen 10.1%. It has been tracked across 43 weekly CMS publications since Dec 10, 2025.
What are the highest and lowest recorded NADAC prices for DIVALPROEX SOD ER 500 MG TAB?
Since Dec 10, 2025, the NADAC for DIVALPROEX SOD ER 500 MG TAB has ranged from a low of $0.1679 (Jan 21, 2026) to a high of $0.1943 (Sep 30, 2026), with a median of $0.1759 per EA.
Are there cheaper alternatives to DIVALPROEX SOD ER 500 MG TAB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DIVALPROEX SOD DR 500 MG TAB, is $0.1608 per EA — about 17% below DIVALPROEX SOD ER 500 MG TAB.
Who manufactures DIVALPROEX SOD ER 500 MG TAB?
DIVALPROEX SOD ER 500 MG TAB (NDC 68001064703) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.